Accurate measurement of pancreatic islet β-cell mass using a second-generation fluorescent exendin-4 analog
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The hallmark of type 1 diabetes is autoimmune destruction of the insulin-producing β-cells of the pancreatic islets. Autoimmune diabetes has been difficult to study or treat because it is not usually diagnosed until substantial β-cell loss has already occurred. Imaging agents that permit noninvasive visualization of changes in β-cell mass remain a high-priority goal. We report on the development and testing of a near-infrared fluorescent β-cell imaging agent. Based on the amino acid sequence of exendin-4, we created a neopeptide via introduction of an unnatural amino acid at the K 12 position, which could subsequently be conjugated to fluorophores via bioorthogonal copper-catalyzed click-chemistry. Cell assays confirmed that the resulting fluorescent probe (E4 ×12 -VT750) had a high binding affinity (∼3 nM). Its in vivo properties were evaluated using high-resolution intravital imaging, histology, whole-pancreas visualization, and endoscopic imaging. According to intravital microscopy, the probe rapidly bound to β-cells and, as demonstrated by confocal microscopy, it was internalized. Histology of the whole pancreas showed a close correspondence between fluorescence and insulin staining, and there was an excellent correlation between imaging signals and β-cell mass in mice treated with streptozotocin, a β-cell toxin. Individual islets could also be visualized by endoscopic imaging. In short, E4 ×12 -VT750 showed strong and selective binding to glucose-like peptide-1 receptors and permitted accurate measurement of β-cell mass in both diabetic and nondiabetic mice. This near-infrared imaging probe, as well as future radioisotope-labeled versions of it, should prove to be important tools for monitoring diabetes, progression, and treatment in both experimental and clinical contexts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One promising approach is to use fluorescent exendin-4 derivatives, which should bind preferentially to β-cells ( 61 , 62 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [61]
Citations
Cites
Looking and listening to light: the evolution of whole-body photonic imaging
Ntziachristos, V., Ripoll, J., Wang, L. V., & Weissleder, R. (2005) · Nature Biotechnology · doi:10.1038/nbt1074 · Cited by 1,557 · cited 1×
“The following technologies have also been advocated because they provide higher spatial resolutions: intravital microscopy (14, 15); tomographic fluorescence imaging at the whole-body (16) or isolated-organ level (17, 18); and, more recently, fiberoptic imaging (19).”
BackgroundSelf-citationMIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266 · cited 1×
“Mouse insulinoma-derived MIN6 cells (34) were used between passages 26 and 40 and were grown in high-glucose DMEM containing 15% (vol/vol) heat-inactivated FBS, 50 U/mL penicillin, and 10 μg/mL streptomycin.”
MethodStreptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes Mellitus
Like, A. A., & Rossini, A. A. (1976) · Science · doi:10.1126/science.180605 · Cited by 979 · cited 1×
“STZ rather specifically kills pancreatic islet β-cells, eventually resulting in insulin-dependent diabetes (27).”
BackgroundIn vivo magnetic resonance imaging of transgene expression
Weissleder, R., Moore, A., Mahmood, U., Bhorade, R., Benveniste, H., Chiocca, E. A., & Basilion, J. P. (2000) · Nature Medicine · doi:10.1038/73219 · Cited by 776 · cited 1×
“Discussion Abundantly and selectively expressed cell-surface receptors have been shown to be good imaging targets, particularly when affinity ligand interaction triggers internalization of the imaging probe and when tissues are well perfused (28, 29).”
BackgroundSelf-citationDetection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle
Kelly, K. A., Allport, J. R., Tsourkas, A., Shinde-Patil, V. R., Josephson, L., & Weissleder, R. (2005) · Circulation Research · doi:10.1161/01.res.0000155722.17881.dd · Cited by 449 · cited 1×
“Discussion Abundantly and selectively expressed cell-surface receptors have been shown to be good imaging targets, particularly when affinity ligand interaction triggers internalization of the imaging probe and when tissues are well perfused (28, 29).”
BackgroundSelf-citationIslet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Ahrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 419 · cited 4×
“GLP-1R is a receptor that is highly expressed on the surface of pancreatic β-cells, and one that binds to the peptide exendin-4 with nanomolar affinity (22, 25).”
BackgroundMethodInfluentialTransgenic mice with green fluorescent protein-labeled pancreatic β-cells
Hara, M., Wang, X., Kawamura, T., Bindokas, V. P., Dizon, R. F., Alcoser, S. Y., Magnuson, M. A., & Bell, G. I. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00321.2002 · Cited by 297
Tomographic molecular imaging and 3D quantification within adult mouse organs
Alanentalo, T., Asayesh, A., Morrison, H., Lorén, C. E., Holmberg, D., Sharpe, J., & Ahlgren, U. (2007) · Nature Methods · doi:10.1038/nmeth985 · Cited by 202 · cited 1×
“The following technologies have also been advocated because they provide higher spatial resolutions: intravital microscopy (14, 15); tomographic fluorescence imaging at the whole-body (16) or isolated-organ level (17, 18); and, more recently, fiberoptic imaging (19).”
BackgroundClinical and Experimental Pancreatic Islet Transplantation to Striated Muscle
Christoffersson, G., Henriksnäs, J., Johansson, L., Rolny, C., Ahlström, H., Caballero-Corbalan, J., Segersvärd, R., Permert, J., Korsgren, O., Carlsson, P.-O., et al. (2010) · Diabetes · doi:10.2337/db10-0205 · Cited by 167 · cited 1×
“The following technologies have also been advocated because they provide higher spatial resolutions: intravital microscopy (14, 15); tomographic fluorescence imaging at the whole-body (16) or isolated-organ level (17, 18); and, more recently, fiberoptic imaging (19).”
BackgroundLongitudinal noninvasive PET-based cell mass estimates in a spontaneous diabetes rat model
Souza, F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27645 · Cited by 143
Widmann, C., Dolci, W., & Thorens, B. (1995) · Biochemical Journal · doi:10.1042/bj3100203 · Cited by 140 · cited 1×
“GLP-1R is a receptor that is highly expressed on the surface of pancreatic β-cells, and one that binds to the peptide exendin-4 with nanomolar affinity (22, 25).”
BackgroundLiew, C. W., Bochenski, J., Kawamori, D., Hu, J., Leech, C. A., Wanic, K., Malecki, M., Warram, J. H., Qi, L., Krolewski, A. S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36849 · Cited by 126
Self-citationSystematic screening of potential β-cell imaging agents
Sweet, I. R., Cook, D. L., Lernmark, Å., Greenbaum, C. J., Wallen, A. R., Marcum, E. S., Stekhova, S. A., & Krohn, K. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.182 · Cited by 107 · cited 1×
“Area [ 2] (488 nm; GFP)”
Noninvasive In Vivo Measurement of β-Cell Mass in Mouse Model of Diabetes
Moore, A., Bonner-Weir, S., & Weissleder, R. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2231 · Cited by 105
Self-citationAlanentalo, T., Hörnblad, A., Mayans, S., Nilsson, A. K., Sharpe, J. A., Larefalk, Å., Ahlgren, U., & Holmberg, D. (2010) · Diabetes · doi:10.2337/db09-1400 · Cited by 101 · cited 1×
“The following technologies have also been advocated because they provide higher spatial resolutions: intravital microscopy (14, 15); tomographic fluorescence imaging at the whole-body (16) or isolated-organ level (17, 18); and, more recently, fiberoptic imaging (19).”
BackgroundBuchner, A. M., Gómez, V., Heckman, M. G., Shahid, M. W., Achem, S. R., Gill, K. R., Laith, J., Kahaleh, M., Lo, S. K., Picco, M. F., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.01.002 · Cited by 96 · cited 1×
“Both laparoscopic imaging and endomicroscopy are rapidly advancing techniques (30, 31) that will benefit greatly from target-specific fluorescent probes.”
BackgroundPositron-Emission Tomography Imaging of Early Events after Transplantation of Islets of Langerhans
Toso, C., Zaidi, H., Morel, P., Armanet, M., Andrès, A., Pernin, N., Baertschiger, R. M., Slosman, D. O., Bühler, L. H., Bosco, D., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000149501.50870.9d · Cited by 92 · cited 1×
“Some of these compounds have already been tested clinically with PET imaging (1, 9, 10).”
BackgroundCurrent Progress in Non-Invasive Imaging of Beta Cell Mass of the Endocrine Pancreas
Souza, F., Freeby, M., Hultman, K. L., Simpson, N. R., Herron, A., Witkowsky, P., Liu, E. V., Maffei, A., & Harris, P. E. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778521940 · Cited by 75
VMAT2 gene expression and function as it applies to imaging β-cell mass
Harris, P. E., Ferrara, C., Barba, P., Polito, T., Freeby, M., & Maffei, A. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0242-x · Cited by 71
Gromada, J., Rorsman, P., Dissing, S., & Wulff, B. S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01070-u · Cited by 66 · cited 1×
“HEK cells stably expressing hGLP-1R (HEK/hGLP-1R) (35) were grown in highglucose DMEM containing 10% (vol/vol) heat-inactivated FBS, 50 U/mL penicillin, 10 μg/mL streptomycin, 1 mM sodium pyruvate, and 150 μg/mL G418 (geneticin).”
MethodNovel Multiwavelength Microscopic Scanner for Mouse Imaging
Alencar, H., Mahmood, U., Kawano, Y., Hirata, T., & Weissleder, R. (2005) · Neoplasia · doi:10.1593/neo.05376 · Cited by 65
Self-citationIntraoperative Near‐Infrared Fluorescent Cholangiography (NIRFC) in Mouse Models of Bile Duct Injury
Figueiredo, J., Siegel, C. D., Nahrendorf, M., & Weissleder, R. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0332-8 · Cited by 58
Self-citationSchneider, S., Feilen, P. J., Schreckenberger, M., Schwanstecher, M., Schwanstecher, C., Buchholz, H. G., Thews, O., Oberholzer, K., Korobeynikov, A., Bauman, A., et al. (2005) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2005-865711 · Cited by 54 · cited 1×
“Previously developed β-cell–specific imaging agents have included labeled glucose analogs (or other small molecules) (1, 2), antibodies (3), sulfonylureas (2, 4), and vesicular monoamine transporter receptor agonists (5, 6).”
BackgroundNear-Infrared Fluorescent Probe for Imaging of Pancreatic β Cells
Reiner, T., Kohler, R. H., Liew, C. W., Hill, J. A., Gaglia, J., Kulkarni, R. N., & Weissleder, R. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100184w · Cited by 48
Self-citationDetection limits of intraoperative near infrared imaging for tumor resection
Thurber, G. M., Figueiredo, J., & Weissleder, R. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21735 · Cited by 47 · cited 1×
“We also envision that the probe may have utility for intraoperative fluorescence imaging of both islets and islet tumors (32, 33).”
BackgroundSelf-citationReal‐time imaging of the pancreas during development of diabetes
Martinic, M. M. A., & von Herrath, M. G. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00581.x · Cited by 46 · cited 1×
“The following technologies have also been advocated because they provide higher spatial resolutions: intravital microscopy (14, 15); tomographic fluorescence imaging at the whole-body (16) or isolated-organ level (17, 18); and, more recently, fiberoptic imaging (19).”
BackgroundTwo-Photon Excitation Imaging of Pancreatic Islets With Various Fluorescent Probes
Takahashi, N., Nemoto, T., Kimura, R., Tachikawa, A., Miwa, A., Okado, H., Miyashita, Y., Iino, M., Kadowaki, T., & Kasai, H. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s25 · Cited by 46
Montanya, E., & Téllez, N. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-448-3_11 · Cited by 45 · cited 1×
“β-cell mass was determined by thresholding and quantitating insulin-positive areas in nonadjacent sections at 50-μm intervals throughout pancreata according to published protocols (39).”
MethodNakamoto, Y., Higashi, T., Sakahara, H., Tamaki, N., ITOH, K., Imamura, M., & Konishi, J. (2000) · Clinical Nuclear Medicine · doi:10.1097/00003072-200002000-00007 · Cited by 45 · cited 2×
“Previously developed β-cell–specific imaging agents have included labeled glucose analogs (or other small molecules) (1, 2), antibodies (3), sulfonylureas (2, 4), and vesicular monoamine transporter receptor agonists (5, 6).”
BackgroundDevelopment of a dual fluorogenic and chromogenic dipeptidyl peptidase IV substrate
Ho, N., Weissleder, R., & Tung, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.02.045 · Cited by 43 · cited 1×
“Based on the clinical success seen with glucagon-like peptide 1 (GLP-1) agonistic approaches (22), we previously designed both dipeptidyl peptidase-4 (23) and GLP-1 receptor (GLP-1R) imaging agents (24).”
MethodSelf-citationNoninvasive imaging of pancreatic β cells
Malaisse, W. J., Louchami, K., & Sener, A. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.103 · Cited by 34
Multimodality Imaging of β-Cells in Mouse Models of Type 1 and 2 Diabetes
Yong, J., Rasooly, J. A., Dang, H. N., Lu, Y., Middleton, B., Zhang, Z., Hon, L., Namavari, M., Stout, D. B., Atkinson, M. A., et al. (2011) · Diabetes · doi:10.2337/db10-0907 · Cited by 32
Confocal laser endomicroscopy of the colon.
Gheonea, D. I., Săftoiu, A., Ciurea, T., Popescu, C. F., Georgescu, C. V., & Maloş, A. (2010) · PubMed · Cited by 31
Lin, K. Y., Maricevich, M., Bardeesy, N. M., Weissleder, R., & Mahmood, U. (2008) · Translational Oncology · doi:10.1593/tlo.08118 · Cited by 30 · cited 1×
“The following technologies have also been advocated because they provide higher spatial resolutions: intravital microscopy (14, 15); tomographic fluorescence imaging at the whole-body (16) or isolated-organ level (17, 18); and, more recently, fiberoptic imaging (19).”
BackgroundSelf-citationApproaches for Imaging Islets: Recent Advances and Future Prospects
Ahlgren, U., & Gotthardt, M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_3 · Cited by 25
Corbin, K. L., Hall, T. E., Haile, R., & Nunemaker, C. S. (2011) · Islets · doi:10.4161/isl.3.1.14133 · Cited by 21 · cited 1×
“Several fluorescent imaging agents that rely on such technologies have been described (20, 21).”
BackgroundTowards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
McGirr, R., Hu, S. L., Yee, S., Kovacs, M. S., Lee, T., & Dhanvantari, S. (2010) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0435-5 · Cited by 20 · cited 1×
“In addition, a variety of transgenic strategies have been applied to mouse models (7, 8).”
MethodIn Vivo Beta-Cell Imaging with VMAT 2 Ligands - Current State-of-the-Art and Future Perspectives
Veluthakal, R., & Harris, P. E. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791164180 · Cited by 19 · cited 1×
“Some of these compounds have already been tested clinically with PET imaging (1, 9, 10).”
BackgroundFigueiredo, J., Nahrendorf, M., Vinegoni, C., & Weissleder, R. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0728-5 · Cited by 6
Self-citationRostovtsev, V. V., Green, L. G., Fokin, V. V., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020715)41:14<2596::aid-anie2596>3.0.co;2-4 · cited 2×
“Binding of GLP-1 to GLP-1R resulted in internalization of the peptide into cells and its localization in endosomal compartments (26).”
BackgroundMethod
Cited by
Managing diabetes with nanomedicine: challenges and opportunities
Veiseh, O., Tang, B. C., Whitehead, K. A., Anderson, D. G., & Langer, R. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4477 · Cited by 613
Pittet, M. J., & Weissleder, R. (2011) · Cell · doi:10.1016/j.cell.2011.11.004 · Cited by 466
“…be achieved by developing cell lines and mouse models with relevant fluorescent reporters (e.g., fusion proteins (Friedman et al., 2010) or FRET sensors (Breart et al., 2008)), or with cellpermeable and fluorescent drugs that have molecular specificity (Budin et al., 2011; Reiner et al., 2011).”
Self-citationβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
“which should bind preferentially to b-cells (61,62).”
Islet β cell mass in diabetes and how it relates to function, birth, and death
Weir, G. C., & Bonner‐Weir, S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12031 · Cited by 296
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“One promising approach is to use fluorescent exendin-4 derivatives, which should bind preferentially to beta cells (61, 62).”
Background
Metadata
- Authors
- Reiner, T., Thurber, G., Gaglia, J., Vinegoni, C., Liew, C. W., Upadhyay, R., Kohler, R. H., Li, L., Kulkarni, R. N., Benoist, C., Mathis, D., & Weissleder, R.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Joslin Diabetes Center (US)
- Center for Systems Biology, Massachusetts General Hospital, Boston, MA 02114; and Departments of
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-07-18
- Volume
- 108
- Issue
- 31
- Pages
- 12815-12820
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3150928
- OpenAlex
- W2001234742
- Cited by
- 120
- References
- 40
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 8 · 2017: 4 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 14 · 2012: 10
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (2r01eb010011-05)
- U.S. Public Health Service (R01 67536)
- National Cancer Institute (U24CA092782)
- National Institute of Allergy and Infectious Diseases (P01-AI54904, P01AI054904)
- National Institute of Diabetes and Digestive and Kidney Diseases (K99DK090210, 1-K99 DK090210-01, R00DK090210)
- National Institute of Biomedical Imaging and Bioengineering (RL9EB008539, R01 EB-010 011, R01EB006432)
- National Center for Research Resources (KL2RR025757)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell mass, fluorescent imaging probes, near-infrared fluorescence, intravital microscopy, endoscopic imaging, streptozotocin-induced diabetes, type 1 diabetes, beta cell imaging
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Exenatide, Amino Acid Sequence, Animals, Binding Sites, Diabetes Mellitus, Type 1, Fluorescent Dyes, Humans, Lysine, Mice, Inbred C57BL, Mice, Transgenic, Microscopy, Fluorescence, Molecular Sequence Data, Pancreas, Peptides, Laparoscopy, Streptozocin, Venoms, Receptors, Glucagon, Microscopy, Confocal, NIH 3T3 Cells, Cell Line, Tumor, Green Fluorescent Proteins, Insulin-Secreting Cells, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.